What is the dosage of Abraxane?

Abraxane is available in 1 dosages, including 100 mg Injection

Last Update: Oct, 06 2024

Abraxane(paclitaxel)

Abraxane 100 MG Injection

Dosage & Administration

* Do not substitute ABRAXANE for other paclitaxel products.
* Extravasation: Closely monitor the infusion site for extravasation and infiltration.
* Metastatic Breast Cancer (MBC): Recommended dosage of ABRAXANE is 260 mg/m2 intravenously over 30 minutes every 3 weeks.
* Non-Small Cell Lung Cancer (NSCLC): Recommended dosage of ABRAXANE is 100 mg/m2 intravenously over 30 minutes on Days 1, 8, and 15 of each 21-day cycle; administer carboplatin on Day 1 of each 21-day cycle immediately after ABRAXANE.
* Adenocarcinoma of the Pancreas: Recommended dosage of ABRAXANE is 125 mg/m2 intravenously over 30-40 minutes on Days 1, 8, and 15 of each 28-day cycle; administer gemcitabine on Days 1, 8, and 15 of each 28-day cycle immediately after ABRAXANE.
* Use in Patients with Hepatic Impairment: ABRAXANE is not recommended for use in patients with AST > 10 × ULN; or bilirubin > 5 × ULN or with metastatic adenocarcinoma of the pancreas who have moderate to severe hepatic impairment. For MBC or NSCLC, reduce starting dose in patients with moderate to severe hepatic impairment.
* Dose Reductions for Adverse Reactions: Dose reductions or discontinuation may be needed based on severe hematologic, neurologic, cutaneous, or gastrointestinal toxicities.

Most viewed Abraxane resources

Enroll in Patient Savings Program

Get Your Patient on Abraxane

Find restrictionsSee step therapiesCompare coverage options

Abraxane Prescribing Information

Contact Medical Science Liaison

Report Adverse Event

Abraxane Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Sep 24, 2024Arizona - Uniform Prior Authorization Form

Verified: Sep 24, 2024Colorado - Uniform Prior Authorization Form

Verified: Sep 24, 2024Hawaii - Uniform Prior Authorization Form

Verified: Sep 24, 2024Illinois - Uniform Prior Authorization Form

Verified: Sep 24, 2024Indiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Louisiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Minnesota - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Mexico - Uniform Prior Authorization Form

Verified: Sep 24, 2024Oregon - Uniform Prior Authorization Form

Verified: Sep 24, 2024Texas - Uniform Prior Authorization Form

Verified: Oct 05, 2024Washington - Uniform Prior Authorization Form

Verified: Oct 05, 2024Wisconsin - Uniform Prior Authorization Form

Commercial Claim Denial Appeal/Redetermination Letter

Coverage Authorization Appeals

Complete Letter of Medical Necessity

Medically Unlikely Edit (MUE) Letter

Benefits investigation

Abraxane Enrollment Form

Abraxane Enrollment Form - Spanish

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

Financial Assistance

Financial Assistance Programs

Q: What does Abraxane treat?

Abraxane treats Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms and Sarcoma, Kaposi

Q: What is Abraxane made of?

Abraxane contains paclitaxel which is a Microtubule Inhibitor

Q: How is Abraxane administered?

Abraxane is administered as a Injectable

Abraxane retails for $1,673 per dose without insurance or financial assistance.Depending on your patient's insurance situation and other eligibility criteria, they may be able to get Abraxane for significantly less. Review the program information below to determine what program can offer your patient the most benefits.

Copay Card Program$0 Copay

Available for

commercial

Program Details